Skip to main content
. 2021 Nov 30;13(12):2049. doi: 10.3390/pharmaceutics13122049

Figure 4.

Figure 4

Plasma concentrations (a) and brain concentrations (b) of tarenflurbil (TFB). Values are expressed as mean ± SD (n = 4). ** p < 0.0001 when compared with TFB administered by IV solution, IN solution and oral suspension, †† p < 0.0001 when compared with TFB-NPs and  p < 0.01 when compared with TFB-NPs. Adapted with permission from [139], Elsevier, 2016.